Lipedema is a chronic condition that occurs almost exclusively in women and manifests as symmetrical buildup of painful fat and swelling in the limbs, sparing the hands and feet. A critical issue is the poorly understood disease biology, which for diagnosed patients results in limited treatment options that, at best, ameliorate the symptoms of lipedema. Individuals who suffer from the disease are further impacted by the absence of diagnostic tools, the lack of public and medical awareness of lipedema, and the stigma associated with weight gain. As a result, the true number of women with lipedema, or its epidemiology, is unknown.
Braving these challenges is an active, numerous, and engaged patient community eager to participate in lipedema research. Supported by equally devoted caregivers and researchers, the lipedema field presents an immense opportunity for scientific and medical advancements. To capitalize on this potential, the Lipedema Foundation and the Milken Institute’s Center for Strategic Philanthropy convened leading stakeholders to discuss the current state of lipedema science and identify the key philanthropic research opportunities to advance the field.
This Giving Smarter Guide describes the current state of research, clinical practice, and treatment approaches for uterine leiomyosarcoma (uLMS) and identifies critical areas where philanthropy can significantly advance scientific knowledge...
Neurodegenerative diseases (ND), including Alzheimer’s disease, Parkinson’s disease, frontotemporal dementia, and others, affect over 50 million people worldwide. The World Health Organization estimates that by the year 2040, NDs will be...
The Ann Theodore Foundation and the Milken Institute are pleased to announce the five research teams selected to receive funding for research to advance understanding of the underlying biology of sarcoidosis, a poorly understood immune...
Type 1 diabetes, or T1D, once commonly known as juvenile diabetes, is an autoimmune disease in which the immune system attacks the insulin-producing cells of the pancreas. The disease affects people of all ages and causes numerous negative...
Glioblastoma Multiforme (GBM) is an aggressive malignant brain tumor involving glial cells of the brain. At the time of this report, nearly 15,000 people were diagnosed with GBM each year in the United States and Europe. The prognosis for...
WASHINGTON, DC (September 20, 2023) — The Ann Theodore Foundation Breakthrough Sarcoidosis Initiative (ATF-BSI), in partnership with the Milken Institute, launched its latest round of funding today.
Tambourine is launching the ALS Breakthrough Research Fund. This new fund will support basic and discover-focused research in amyotrophic lateral sclerosis (ALS).
Situation Sarcoidosis is defined by the dramatic accumulation of granulomas—dense clusters of immune cells—in organs throughout the body. Individuals living with sarcoidosis often go undiagnosed for years, enduring symptoms such as...
Misophonia was named and described in the early 2000’s (Jastreboff and Jastreboff, 2001, 2002) and has since gained scientific recognition and clinical identification across a wide variety of disciplines (e.g., audiology, neuroscience...